Bright Minds Biosciences Inc. Gains 117.56%
Fri, Oct 18, 2024 at 07:40 PM
Bright Minds Biosciences Inc. (DRUG:NASDAQ) rocketted at $47.21, a gain of 117.6%. On Fri, Oct 18, 2024, DRUG:NASDAQ hit a New 2-Week High of $47.21. The stock got featured on our News Catalysts scanner on Fri, Oct 18, 2024 at 07:59 AM in the 'PRIVATE PLACEMENT' category. From Fri, Oct 04, 2024, the stock recorded 50.00% Up Days and 63.64% Green Days
The stock spiked on Fri, Oct 18, 2024 at $79.02 with a volume of 26M+.
About Bright Minds Biosciences Inc. (DRUG:NASDAQ)
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain.
Top 10 Gainers:
- Bright Minds Biosciences Inc. (DRUG:NASDAQ), 117.56%
- Catheter Precision Inc Com Par $ 0.001 (VTAK:NYSEMKT), 106.49%
- D-Market Electronic Services & Trading (HEPS:NASDAQ), 59.55%
- Lightbridge Corporation (LTBR:NASDAQ), 57.53%
- Pineapple Holdings Inc Com (PEGY:NASDAQ), 47.91%
- Firefly Neuroscience Inc Com (AIFF:NASDAQ), 42.61%
- Inno Holdings Inc. (INHD:NASDAQ), 41.75%
- Oriental Culture Holding LTD (OCG:NASDAQ), 38.98%
- Bridger Aerospace Group Holdings Inc. (BAER:NASDAQ), 35.78%
- Austin Gold Corp. (AUST:NYSEMKT), 35%